Rewriting the rules for care of MDS and AML patients in the time of COVID-19

The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably select...

Full description

Bibliographic Details
Main Authors: Azra Raza, Amer Assal, Abdullah M. Ali, Joseph G. Jurcic
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Leukemia Research Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048920300078